Atai Beckley CEO Highlights Progress After NASDAQ Biotech Index Inclusion
Atai Beckley CEO Srinivas Rao noted pipeline progress and a strong foundation after the company joined the NASDAQ Biotechnology Index, following a $300 million capital raise and a strategic partnership.